E

EyePoint Pharmaceuticals
D

EYPT

9.70000
USD
0.06
(0.62%)
مغلق
حجم التداول
10,091
الربح لكل سهم
-3
العائد الربحي
-
P/E
-4
حجم السوق
667,473,839
أصول ذات صلة
ABBV
ABBV
-1.530
(-0.80%)
189.200 USD
AMGN
AMGN
1.79
(0.60%)
298.52 USD
BMY
BMY
-0.525
(-1.10%)
47.080 USD
CVS
CVS
0.670
(1.01%)
67.260 USD
GE
GE
2.280
(0.93%)
246.780 USD
HCA
HCA
-1.80
(-0.48%)
376.30 USD
IBM
IBM
3.90
(1.36%)
291.52 USD
LLY
LLY
0.55
(0.07%)
779.65 USD
UNH
UNH
1.09
(0.35%)
308.65 USD
المزيد
الأخبار المقالات

العنوان: EyePoint Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.